TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu. (Editor:Fu Bo) |
Judge OKs phone surveys of jury pool for man charged in 4 University of Idaho student deathsTiger Woods FINALLY reveals the three stars joining his TGL team next yearThe UK pledges $620 million in new military aid for UkraineMilwaukee man charged in dismemberment death pleads not guiltyTom Holland confirms he is definitely returning for a fourth SpiderSpain reopens a probe into a Pegasus spyware case after a French request to work togetherJudge OKs phone surveys of jury pool for man charged in 4 University of Idaho student deathsKhloe Kardashian shares sweet photo of 'miniGloRilla hits back at NBA star Damian Lillard's estranged wife who trolled her for DUI arrestAboriginal spears taken by Captain Cook in 1770 are returned to Australia's Indigenous people